Medical - Devices
Compare Stocks
5 / 10Stock Comparison
NNOX vs HOLO vs ATEC vs PRCT vs GEHC
Revenue, margins, valuation, and 5-year total return — side by side.
Hardware, Equipment & Parts
Medical - Devices
Medical - Devices
Medical - Healthcare Information Services
NNOX vs HOLO vs ATEC vs PRCT vs GEHC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Medical - Devices | Hardware, Equipment & Parts | Medical - Devices | Medical - Devices | Medical - Healthcare Information Services |
| Market Cap | $115M | $3M | $1.17B | $1.45B | $27.90B |
| Revenue (TTM) | $12M | $321M | $595M | $322M | $19.95B |
| Net Income (TTM) | $-56M | $295M | $-125M | $-102M | $1.50B |
| Gross Margin | -98.8% | 24.2% | 89.6% | 63.0% | 42.5% |
| Operating Margin | -469.7% | -1.1% | -9.6% | -33.9% | 12.5% |
| Forward P/E | — | — | 27.1x | — | 12.4x |
| Total Debt | $7M | $8M | $620M | $52M | $10.00B |
| Cash & Equiv. | $39M | $851M | $161M | $287M | $4.51B |
NNOX vs HOLO vs ATEC vs PRCT vs GEHC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Dec 22 | May 26 | Return |
|---|---|---|---|
| Nano-X Imaging Ltd. (NNOX) | 100 | 23.8 | -76.2% |
| MicroCloud Hologram… (HOLO) | 100 | 0.0 | -100.0% |
| Alphatec Holdings, … (ATEC) | 100 | 62.8 | -37.2% |
| PROCEPT BioRobotics… (PRCT) | 100 | 61.2 | -38.8% |
| GE HealthCare Techn… (GEHC) | 100 | 105.1 | +5.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NNOX vs HOLO vs ATEC vs PRCT vs GEHC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NNOX lags the leaders in this set but could rank higher in a more targeted comparison.
HOLO carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth 42.6%, EPS growth 94.2%, 3Y rev CAGR -6.8%
- 42.6% revenue growth vs GEHC's 4.8%
- 91.9% margin vs NNOX's -452.8%
- 10.0% ROA vs NNOX's -31.6%, ROIC -27.3% vs -27.9%
ATEC ranks third and is worth considering specifically for income & stability.
- beta 1.13
- Beta 1.13 vs HOLO's 2.19
PRCT is the clearest fit if your priority is sleep-well-at-night and defensive.
- Lower volatility, beta 1.23, Low D/E 14.1%, current ratio 6.85x
- Beta 1.23, current ratio 6.85x
GEHC is the #2 pick in this set and the best alternative if long-term compounding is your priority.
- 2.9% 10Y total return vs ATEC's 225.4%
- Better valuation composite
- 0.2% yield; 3-year raise streak; the other 4 pay no meaningful dividend
- -10.7% vs HOLO's -78.7%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 42.6% revenue growth vs GEHC's 4.8% | |
| Value | Better valuation composite | |
| Quality / Margins | 91.9% margin vs NNOX's -452.8% | |
| Stability / Safety | Beta 1.13 vs HOLO's 2.19 | |
| Dividends | 0.2% yield; 3-year raise streak; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | -10.7% vs HOLO's -78.7% | |
| Efficiency (ROA) | 10.0% ROA vs NNOX's -31.6%, ROIC -27.3% vs -27.9% |
NNOX vs HOLO vs ATEC vs PRCT vs GEHC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
NNOX vs HOLO vs ATEC vs PRCT vs GEHC — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
GEHC leads in 2 of 6 categories
HOLO leads 1 • PRCT leads 1 • NNOX leads 0 • ATEC leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
HOLO leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
GEHC is the larger business by revenue, generating $20.0B annually — 1622.0x NNOX's $12M. HOLO is the more profitable business, keeping 91.9% of every revenue dollar as net income compared to NNOX's -4.5%. On growth, HOLO holds the edge at +24.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $12M | $321M | $595M | $322M | $20.0B |
| EBITDAEarnings before interest/tax | -$46M | -$3M | $4M | -$102M | $3.3B |
| Net IncomeAfter-tax profit | -$56M | $295M | -$125M | -$102M | $1.5B |
| Free Cash FlowCash after capex | -$47M | $47M | $7M | -$81M | $1.5B |
| Gross MarginGross profit ÷ Revenue | -98.8% | +24.2% | +89.6% | +63.0% | +42.5% |
| Operating MarginEBIT ÷ Revenue | -4.7% | -1.1% | -9.6% | -33.9% | +12.5% |
| Net MarginNet income ÷ Revenue | -4.5% | +91.9% | -21.1% | -31.8% | +7.5% |
| FCF MarginFCF ÷ Revenue | -3.8% | +14.7% | +1.2% | -25.0% | +7.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +13.7% | +24.0% | -100.0% | +20.2% | +7.4% |
| EPS Growth (YoY)Latest quarter vs prior year | +8.7% | +153.4% | +37.1% | -24.4% | -30.9% |
Valuation Metrics
GEHC leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, GEHC's 10.0x EV/EBITDA is more attractive than ATEC's 3752.1x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $115M | $3M | $1.2B | $1.4B | $27.9B |
| Enterprise ValueMkt cap + debt − cash | $83M | -$121M | $1.6B | $1.2B | $33.4B |
| Trailing P/EPrice ÷ TTM EPS | -1.93x | -0.27x | -8.07x | -14.79x | 13.48x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 27.09x | — | 12.40x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | 19.78x |
| EV / EBITDAEnterprise value multiple | — | — | 3752.09x | — | 10.00x |
| Price / SalesMarket cap ÷ Revenue | 10.20x | 0.06x | 1.54x | 4.70x | 1.35x |
| Price / BookPrice ÷ Book value/share | 0.55x | 0.01x | 32.28x | 3.86x | 2.66x |
| Price / FCFMarket cap ÷ FCF | — | — | 422.56x | — | 18.53x |
Profitability & Efficiency
GEHC leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
GEHC delivers a 14.4% return on equity — every $100 of shareholder capital generates $14 in annual profit, vs $-4 for ATEC. HOLO carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to ATEC's 17.21x. On the Piotroski fundamental quality scale (0–9), ATEC scores 6/9 vs HOLO's 3/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -35.5% | +10.3% | -4.4% | -27.7% | +14.4% |
| ROA (TTM)Return on assets | -31.6% | +10.0% | -15.8% | -20.3% | +4.1% |
| ROICReturn on invested capital | -27.9% | -27.3% | -12.6% | -55.7% | +13.3% |
| ROCEReturn on capital employed | -28.4% | -16.0% | -13.7% | -22.5% | +10.8% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 3 | 6 | 5 | 4 |
| Debt / EquityFinancial leverage | 0.04x | 0.00x | 17.21x | 0.14x | 0.94x |
| Net DebtTotal debt minus cash | -$32M | -$844M | $459M | -$235M | $5.5B |
| Cash & Equiv.Liquid assets | $39M | $851M | $161M | $287M | $4.5B |
| Total DebtShort + long-term debt | $7M | $8M | $620M | $52M | $10.0B |
| Interest CoverageEBIT ÷ Interest expense | -379.29x | — | -3.29x | -30.92x | 5.35x |
Total Returns (Dividends Reinvested)
PRCT leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in GEHC five years ago would be worth $10,293 today (with dividends reinvested), compared to $0 for HOLO. Over the past 12 months, GEHC leads with a -10.7% total return vs HOLO's -78.7%. The 3-year compound annual growth rate (CAGR) favors PRCT at -2.7% vs HOLO's -95.1% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -37.8% | -37.9% | -62.7% | -17.3% | -25.9% |
| 1-Year ReturnPast 12 months | -64.4% | -78.7% | -37.8% | -52.1% | -10.7% |
| 3-Year ReturnCumulative with dividends | -89.2% | -100.0% | -47.8% | -7.8% | -22.2% |
| 5-Year ReturnCumulative with dividends | -93.9% | -100.0% | -48.7% | -39.3% | +2.9% |
| 10-Year ReturnCumulative with dividends | -96.1% | -100.0% | +225.4% | -39.3% | +2.9% |
| CAGR (3Y)Annualised 3-year return | -52.4% | -95.1% | -19.5% | -2.7% | -8.0% |
Risk & Volatility
Evenly matched — ATEC and GEHC each lead in 1 of 2 comparable metrics.
Risk & Volatility
ATEC is the less volatile stock with a 1.13 beta — it tends to amplify market swings less than HOLO's 2.19 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. GEHC currently trades 68.3% from its 52-week high vs HOLO's 14.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.86x | 2.19x | 1.13x | 1.23x | 1.37x |
| 52-Week HighHighest price in past year | $5.86 | $11.82 | $23.29 | $66.85 | $89.77 |
| 52-Week LowLowest price in past year | $1.66 | $1.54 | $6.85 | $19.35 | $58.75 |
| % of 52W HighCurrent price vs 52-week peak | +30.0% | +14.6% | +33.3% | +38.1% | +68.3% |
| RSI (14)Momentum oscillator 0–100 | 38.5 | 43.3 | 26.8 | 50.9 | 32.1 |
| Avg Volume (50D)Average daily shares traded | 1.4M | 722K | 3.0M | 1.7M | 4.3M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: NNOX as "Buy", ATEC as "Buy", PRCT as "Buy", GEHC as "Buy". Consensus price targets imply 922.7% upside for NNOX (target: $18) vs 36.9% for GEHC (target: $84). GEHC is the only dividend payer here at 0.23% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | — | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $18.00 | — | $25.00 | $44.50 | $84.00 |
| # AnalystsCovering analysts | 5 | — | 16 | 15 | 18 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — | +0.2% |
| Dividend StreakConsecutive years of raises | — | — | — | — | 3 |
| Dividend / ShareAnnual DPS | — | — | — | — | $0.14 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% | 0.0% | +0.7% |
GEHC leads in 2 of 6 categories (Valuation Metrics, Profitability & Efficiency). HOLO leads in 1 (Income & Cash Flow). 1 tied.
NNOX vs HOLO vs ATEC vs PRCT vs GEHC: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is NNOX or HOLO or ATEC or PRCT or GEHC a better buy right now?
For growth investors, MicroCloud Hologram Inc.
(HOLO) is the stronger pick with 42. 6% revenue growth year-over-year, versus 4. 8% for GE HealthCare Technologies Inc. (GEHC). GE HealthCare Technologies Inc. (GEHC) offers the better valuation at 13. 5x trailing P/E (12. 4x forward), making it the more compelling value choice. Analysts rate Nano-X Imaging Ltd. (NNOX) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — NNOX or HOLO or ATEC or PRCT or GEHC?
On forward P/E, GE HealthCare Technologies Inc.
is actually cheaper at 12. 4x.
03Which is the better long-term investment — NNOX or HOLO or ATEC or PRCT or GEHC?
Over the past 5 years, GE HealthCare Technologies Inc.
(GEHC) delivered a total return of +2. 9%, compared to -100. 0% for MicroCloud Hologram Inc. (HOLO). Over 10 years, the gap is even starker: ATEC returned +225. 4% versus HOLO's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — NNOX or HOLO or ATEC or PRCT or GEHC?
By beta (market sensitivity over 5 years), Alphatec Holdings, Inc.
(ATEC) is the lower-risk stock at 1. 13β versus MicroCloud Hologram Inc. 's 2. 19β — meaning HOLO is approximately 95% more volatile than ATEC relative to the S&P 500. On balance sheet safety, MicroCloud Hologram Inc. (HOLO) carries a lower debt/equity ratio of 0% versus 17% for Alphatec Holdings, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — NNOX or HOLO or ATEC or PRCT or GEHC?
By revenue growth (latest reported year), MicroCloud Hologram Inc.
(HOLO) is pulling ahead at 42. 6% versus 4. 8% for GE HealthCare Technologies Inc. (GEHC). On earnings-per-share growth, the picture is similar: MicroCloud Hologram Inc. grew EPS 94. 2% year-over-year, compared to 1. 7% for PROCEPT BioRobotics Corporation. Over a 3-year CAGR, NNOX leads at 105. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — NNOX or HOLO or ATEC or PRCT or GEHC?
GE HealthCare Technologies Inc.
(GEHC) is the more profitable company, earning 10. 1% net margin versus -474. 3% for Nano-X Imaging Ltd. — meaning it keeps 10. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GEHC leads at 13. 4% versus -502. 9% for NNOX. At the gross margin level — before operating expenses — ATEC leads at 69. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is NNOX or HOLO or ATEC or PRCT or GEHC more undervalued right now?
On forward earnings alone, GE HealthCare Technologies Inc.
(GEHC) trades at 12. 4x forward P/E versus 27. 1x for Alphatec Holdings, Inc. — 14. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NNOX: 922. 7% to $18. 00.
08Which pays a better dividend — NNOX or HOLO or ATEC or PRCT or GEHC?
In this comparison, GEHC (0.
2% yield) pays a dividend. NNOX, HOLO, ATEC, PRCT do not pay a meaningful dividend and should not be held primarily for income.
09Is NNOX or HOLO or ATEC or PRCT or GEHC better for a retirement portfolio?
For long-horizon retirement investors, Alphatec Holdings, Inc.
(ATEC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 13), +225. 4% 10Y return). MicroCloud Hologram Inc. (HOLO) carries a higher beta of 2. 19 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ATEC: +225. 4%, HOLO: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between NNOX and HOLO and ATEC and PRCT and GEHC?
These companies operate in different sectors (NNOX (Healthcare) and HOLO (Technology) and ATEC (Healthcare) and PRCT (Healthcare) and GEHC (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: NNOX is a small-cap quality compounder stock; HOLO is a small-cap high-growth stock; ATEC is a small-cap high-growth stock; PRCT is a small-cap high-growth stock; GEHC is a mid-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.